Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 61 | 1 | 72 | +12 |
| Shares | 33.3M | 186.4K | 35.5M | +2.40M (+7.2%) |
| Value | $513.8M | $2.88M | $449.1M | −$61.8M (−12.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Samlyn Capital, LLC | 741,633 | $9.38M | 0.14% |
| Pictet Asset Management SA | 185,903 | $2.35M | 0.00% |
| Point72 Asset Management, L.P. | 93,960 | $1.19M | 0.01% |
| Endurant Capital Management LP | 90,041 | $1.14M | 0.35% |
| Tekla Capital Management LLC | 65,025 | $823.0K | 0.03% |
| DuPont Capital Management Corp | 26,748 | $338.0K | 0.01% |
| Qube Research & Technologies Ltd | 15,002 | $190.0K | 0.00% |
| Virtu Financial LLC | 14,584 | $184.0K | 0.02% |
| SG Americas Securities, LLC | 14,079 | $178.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 11,017 | $139.0K | 0.00% |
| MetLife Investment Management | 9,513 | $120.3K | 0.00% |
| Metropolitan Life Insurance Co | 7,197 | $91.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 7,207 | $91.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,094 | $26.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 400 | $5.00K | 0.00% |
| US Bancorp | 235 | $3.00K | 0.00% |
| UBS Group AG | 265 | $3.00K | 0.00% |
| Signaturefd, LLC | 156 | $2.00K | 0.00% |
| Ellevest, Inc. | 2 | $0 | 0.00% |
Sold out (7)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Franklin Resources Inc | 150,000 | $2.32M |
| Boxer Capital, LLC | 50,000 | $773.0K |
| Nantahala Capital Management, LLC | 50,000 | $773.0K |
| Maven Securities LTD | 25,184 | $390.0K |
| Prudential Financial Inc | 20,090 | $311.0K |
| Two Sigma Investments, LP | 12,284 | $190.0K |
| Tarbox Family Office, Inc. | 1,000 | $15.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 186,433 | $2.88M |